nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.0951	0.103	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0259	0.0279	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0258	0.0278	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0254	0.0274	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0253	0.0273	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0218	0.0235	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0217	0.0234	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0213	0.023	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0212	0.0229	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0154	0.0166	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0153	0.0165	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0148	0.0159	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0147	0.0159	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0143	0.0154	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0142	0.0154	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0138	0.0149	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0138	0.0149	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0136	0.0147	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0135	0.0146	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0134	0.0145	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0134	0.0144	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0129	0.0139	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0129	0.0139	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0125	0.0135	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0125	0.0135	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.012	0.013	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.012	0.0129	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0116	0.0126	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0116	0.0125	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0114	0.0123	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0114	0.0123	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0113	0.0122	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0112	0.0121	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0105	0.0113	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0105	0.0113	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00876	0.00946	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00873	0.00943	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00736	0.00795	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00734	0.00792	CbGpPWpGaD
Doxylamine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.00635	0.0861	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00499	0.00539	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00498	0.00537	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00489	0.00528	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00488	0.00526	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00488	0.00526	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00486	0.00524	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00484	0.00523	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00428	0.00462	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00426	0.0046	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.0042	0.0569	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0042	0.00453	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00419	0.00453	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00418	0.00451	CbGpPWpGaD
Doxylamine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.0039	0.0529	CrCbGaD
Doxylamine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00355	0.0482	CrCbGaD
Doxylamine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00353	0.0478	CrCbGaD
Doxylamine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00348	0.0472	CrCbGaD
Doxylamine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.00345	0.0468	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00339	0.00366	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00338	0.00365	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00335	0.00362	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00335	0.00362	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00326	0.00352	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00325	0.00351	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00325	0.00351	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00319	0.00345	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00318	0.00343	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00315	0.0034	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00314	0.0426	CrCbGaD
Doxylamine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00313	0.00338	CbGpPWpGaD
Doxylamine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00306	0.0415	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00296	0.0032	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00295	0.00319	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00294	0.00317	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00291	0.00314	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0029	0.00313	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00276	0.00297	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00275	0.00297	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00275	0.00296	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00274	0.00295	CbGpPWpGaD
Doxylamine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.00271	0.0367	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00267	0.00288	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00266	0.00287	CbGpPWpGaD
Doxylamine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00264	0.0358	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00262	0.00283	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00261	0.00282	CbGpPWpGaD
Doxylamine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00259	0.0351	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00259	0.0028	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00258	0.00279	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00254	0.00274	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00253	0.00273	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00249	0.00269	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00248	0.00268	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00241	0.00261	CbGpPWpGaD
Doxylamine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00241	0.0327	CrCbGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00241	0.0026	CbGpPWpGaD
Doxylamine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00237	0.0321	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00236	0.00255	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00235	0.00254	CbGpPWpGaD
Doxylamine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.0023	0.0311	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00229	0.00247	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00228	0.00246	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00225	0.00243	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00224	0.00242	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00222	0.0024	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00221	0.00239	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00221	0.00239	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00221	0.00238	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00219	0.00236	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00218	0.00235	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.00215	0.0292	CrCbGaD
Doxylamine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.00209	0.0284	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00207	0.00223	CbGpPWpGaD
Doxylamine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.00207	0.028	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00206	0.00223	CbGpPWpGaD
Doxylamine—Doxepin—DRD2—attention deficit hyperactivity disorder	0.00206	0.0279	CrCbGaD
Doxylamine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00203	0.0275	CrCbGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00196	0.00211	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00195	0.0021	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00193	0.00209	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00193	0.00208	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00199	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00198	CbGpPWpGaD
Doxylamine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00183	0.0248	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0018	0.00195	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0018	0.00194	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0018	0.00194	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00179	0.00193	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00174	0.00188	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00174	0.00187	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.00185	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00171	0.00184	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00169	0.00182	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00169	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00168	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00168	0.00182	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.00181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.0018	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00164	0.00177	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00163	0.00176	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.00161	0.0218	CrCbGaD
Doxylamine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.0016	0.0217	CrCbGaD
Doxylamine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.0016	0.0217	CrCbGaD
Doxylamine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.00159	0.0216	CrCbGaD
Doxylamine—Doxepin—HTR2A—attention deficit hyperactivity disorder	0.00159	0.0215	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00157	0.0017	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00157	0.00169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00147	0.00159	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00147	0.00158	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00145	0.00156	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00144	0.00156	CbGpPWpGaD
Doxylamine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.00141	0.0191	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00125	0.00135	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00125	0.00135	CbGpPWpGaD
Doxylamine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.00124	0.0168	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.00123	0.0167	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00115	0.00124	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00115	0.00124	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00114	0.00123	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00113	0.00122	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00119	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00119	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00109	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00109	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00109	0.00118	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00102	0.0011	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00101	0.00109	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000992	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000989	0.00107	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000988	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000985	0.00106	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000984	0.00106	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000981	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000968	0.00104	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000967	0.00104	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000965	0.00104	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000964	0.00104	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000955	0.00103	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000952	0.00103	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000949	0.00102	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000946	0.00102	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000923	0.000996	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00092	0.000993	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000894	0.000965	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000891	0.000962	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00089	0.000961	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000887	0.000958	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000878	0.000948	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000875	0.000945	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000867	0.000937	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000865	0.000934	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000808	0.000872	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000806	0.00087	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000671	0.000724	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000669	0.000722	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000623	0.000673	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000621	0.000671	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000586	0.000633	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000584	0.000631	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000566	0.000611	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000564	0.000609	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000545	0.000588	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000543	0.000587	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000528	0.00057	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000526	0.000568	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000519	0.00056	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000517	0.000558	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000512	0.000553	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000511	0.000551	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000477	0.000515	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000476	0.000514	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000334	0.000361	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000333	0.00036	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000177	0.000191	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000177	0.000191	CbGpPWpGaD
